Gene: RCCD1
Official Full Name: RCC1 domain containing 1provided by HGNC
Gene Summary: Predicted to be involved in chromatin organization. Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23470 | RCCD1 Knockout cell line (HeLa) | Human | RCCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO23471 | RCCD1 Knockout cell line (HCT 116) | Human | RCCD1 | 1:2~1:4 | Negative | Online Inquiry |
KO23472 | RCCD1 Knockout cell line (HEK293) | Human | RCCD1 | 1:3~1:6 | Negative | Online Inquiry |
KO23473 | RCCD1 Knockout cell line (A549) | Human | RCCD1 | 1:3~1:4 | Negative | Online Inquiry |
RCCD1 Gene Knockout Cell Lines are genetically modified cell cultures where the RCCD1 gene has been selectively inactivated, resulting in a loss-of-function model that enables researchers to study the biological roles and regulatory mechanisms associated with this gene. RCCD1, known for its involvement in various cellular processes such as ribosome biogenesis, mRNA metabolism, and cellular stress response, serves as a critical target for understanding pathophysiological conditions, including cancer.
The knockout approach utilized in these cell lines allows scientists to dissect the specific contributions of RCCD1 to cellular dynamics. By observing the phenotypic and functional changes that occur post-knockout, researchers can elucidate molecular pathways and identify potential therapeutic targets. The product employs cutting-edge CRISPR-Cas9 technology for precise gene editing, ensuring high knockout efficiency while minimizing off-target effects, thereby maintaining the integrity of the genomic landscape.
In research and clinical settings, RCCD1 Gene Knockout Cell Lines hold significant promise. Their application ranges from basic research in cell biology to translational studies aimed at therapeutic interventions for diseases related to RCCD1 dysregulation. The model is invaluable for screening drug candidates, examining genetic interactions, and advancing personalized medicine approaches.
Unique advantages of these cell lines include their high fidelity in mimicking the physiological state of RCCD1-deficient conditions, along with comprehensive support from our expert team that assists researchers in experimental design and troubleshooting. This product stands out due to its ability to enhance experimental outcomes and streamline research processes, making it an essential tool for advancing scientific knowledge.
Our company prides itself on its dedication to innovation in genetic engineering and commitment to quality, offering a wide range of biological products designed to propel your research to new heights. With our expertise and these RCCD1 Gene Knockout Cell Lines, researchers can unlock new insights into gene function and disease mechanisms, promoting significant advancements in the field of molecular biology and clinical therapeutics.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.